Breast Cancer
Online ISSN : 1880-4233
Print ISSN : 1340-6868
ISSN-L : 1340-6868
Review Articles
Radiofrequency Ablation Therapy in Patients with Breast Cancers Two Centimeters or Less in Size
Shoji OuraTakeshi TamakiIssei HiraiTatsuya YoshimasuFuminori OhtaRie NakamuraYoshitaka Okamura
著者情報
ジャーナル フリー

2007 年 14 巻 1 号 p. 48-54

詳細
抄録
Background: Non-surgical ablation is an attractive approach as a local control method for breast cancer. The purpose of this study was to investigate the complications and efficacy of radiofrequency ablation (RFA) therapy for breast cancer.
Methods: A total of 52 patients with breast cancer were enrolled. The mean tumor size was 1.3 cm (range, 0.5-2.0 cm). Under general anesthesia, RFA was done with a Cool-tip RF system after sentinel node biopsy. All patients received one session of RFA, for a maximum time of 30 minutes for the first 29 patients and 15 minutes for the following 23 patients when so-called 'break', i.e. stopping the delivery of radiofrequency, did not occur. Postoperative cytological evaluation was done 3-4 weeks after operation. Adjuvant therapy consisted of chemo- and/or endocrine-therapy and radiotherapy (50Gy).
Results: The mean time of RFA was 12 minutes (5-25 minutes). One patient (2%) was troubled with a skin burn just above the ablated field. No patient had viable cancer cells on post-operative cytological evaluation. No recurrence developed 15 months on the average after RFA (6-30 months). Cosmesis after RFA was excellent in 43 patients (83%), good in 6 (12%), and fair in 3 (6%).
Conclusion: RFA can be safely used for breast cancer and provides good local control and excellent cosmesis to patients with small breast cancers.
著者関連情報

この記事は最新の被引用情報を取得できません。

© 2007 by The Japanese Breast Cancer Society
前の記事 次の記事
feedback
Top